Cloprostenol sodium 0.263 mg, excipients q.s. ad 1 mL.
Lutaprost® 250
Injectable Solution
Luteolytic agent of reduced dose
Formulation
Indications
Synthetic analog of prostaglandin, structurally related to prostaglandin F2a. Powerful luteolytic agent that induces functional and morphological regression of the luteal body (luteolysis). After 2 to 4 days, luteolysis is followed by return to oestrus with normal ovulation. Its clinical applications can vary according to the target specie.
Dosage and Administration
Cows: 2 mL (intramuscular) or 1 mL (submucous-intravulvar): mares: 1 mL (intramuscular); sows: 0.7 mL (intramuscular) or 0.35 mL (submucous-intravulvar); sheep and goats: 0.6 mL (intramuscular) or 0.15 mL (submucous-intravulvar); camelids: 1 mL (intramuscular).
Commercial Presentation
Bottle x 10 mL , Bottle x 20 mL , Bottle x 30 mL ,
registro MAGFOR
SENASA Perú: F.16.01.N.0139
MORE VISITED PRODUCTS
ChickVit® ESe OS
Oral SolutionMicroemulsified and Ballanced Association of Vitamin E with Organic Chelated Selenium
